01134.HK
Kelfred Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 0.23
−2.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 976.0M | 500.3M | 453.6M | 393.3M | 465.4M |
| Cost of Revenue | 866.9M | 440.9M | 408.9M | 336.3M | 389.4M |
| Gross Profit | 109.2M | 59.3M | 44.7M | 57.0M | 76.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 155.6M | 76.8M | 76.9M | 77.3M | 78.2M |
| General & Admin Expense | 92.0M | 60.5M | 62.0M | 60.2M | 63.6M |
| Selling & Marketing Expense | 26.3M | 16.9M | 14.8M | 17.1M | 14.6M |
| Other Expenses | (12.7M) | (6.4M) | (12.8M) | (24.1M) | (13.6M) |
| Total Operating Expenses | 143.0M | 70.4M | 64.1M | 53.1M | 64.6M |
| Cost and Expenses | 1.0B | 511.3M | 473.0M | 389.5M | 454.0M |
| Operating Income (EBIT) | (33.8M) | (11.1M) | (19.5M) | 3.8M | 11.4M |
| Non-Operating | |||||
| Interest Income | 21.0K | 9.0K | 17.0K | 25.0K | 25.0K |
| Interest Expense | 5.0M | 2.6M | 2.0M | 1.7M | 740.0K |
| Net Interest Income | (5.0M) | (2.6M) | (2.0M) | (1.7M) | (715.0K) |
| Other Non-Op Income/Expense | (1.1M) | (2.6M) | (2.0M) | (1.7M) | (715.0K) |
| Non-Operating Income (excl Interest) | (2.8M) | (3.8M) | 4.3M | (25.0K) | (19.0K) |
| EBT (Pre-Tax Income) | (34.9M) | (13.7M) | (21.4M) | 2.2M | 10.7M |
| Income Tax Expense | 1.7M | 1.4M | 195.0K | 790.0K | 1.5M |
| Bottom Line | |||||
| Net Income | (36.5M) | (15.1M) | (21.6M) | 1.4M | 9.2M |
| Earnings from Cont. Ops | (36.6M) | (15.2M) | (21.6M) | 1.4M | 9.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (36.5M) | (15.1M) | (21.6M) | 1.4M | 9.2M |
| Per Share | |||||
| Basic EPS | (HK$0.07) | (HK$0.03) | (HK$0.04) | HK$0.00 | HK$0.02 |
| Diluted EPS | (HK$0.07) | (HK$0.03) | (HK$0.04) | HK$0.00 | HK$0.02 |
| Revenue Per Share | HK$1.95 | HK$1.00 | HK$0.91 | HK$0.79 | HK$0.93 |
| Shares | |||||
| Basic Shares Outstanding | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M |
| Diluted Shares Outstanding | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M |
| Profitability Metrics | |||||
| EBITDA | (13.4M) | 1.2M | (17.1M) | 14.2M | 21.1M |
| D&A | 17.6M | 8.5M | 6.6M | 10.4M | 9.7M |
| EBIT | (31.0M) | (7.3M) | (23.7M) | 3.9M | 11.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026